Related references
Note: Only part of the references are listed.Intramuscular Anti-D treatment for immune thrombocytopenia: A single centre experience
Sunil Lakhwani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia
Madhavi Lakkaraja et al.
TRANSFUSION (2016)
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)
Jenny M. Despotovic et al.
TRANSFUSION (2012)
Single dose of ANTI-D immune globulin at 75μg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children
Michael D. Tarantino et al.
JOURNAL OF PEDIATRICS (2006)
Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura
AR Gaines
BLOOD (2005)
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms:: modulation of cytokine and platelet responses to IV anti-D by FcγRIIa and FcγRIIIa polymorphisms
N Cooper et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
A dose of 75 μg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura
GC Newman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
